Member Login

Executive Committee

Allergens to be considered for inclusion in the nomenclature are reviewed by the Executive Committee which is currently chaired by Dr. Richard E. Goodman (University of Nebraska-Lincoln, USA). The committee has nineteen members from academia, government regulatory agencies and industry who are leading experts in allergen characterization, structure and function (see Table).

The committee meets annually or bi-annually at international allergy/immunology meetings and discusses any proposed changes or additions to the nomenclature. There is also a committee-at-large, which is open to any scientist with an interest in allergens, to whom decisions made by the Executive Committee are circulated.

Procedures for submission and review of candidate names for new allergens are given under the Submission Form section of this website. Once the New Allergen Submission Form has been completed and reviewed, the Sub-committee reviewers will provisionally accept the author's suggested allergen name, or assign the allergen a name, provided that the inclusion criteria are satisfied. Occasionally, the Sub-committee has to resolve differences between investigators who may be using different names for the same allergen, or disputes concerning the chronological order of allergen identification. These issues can normally be resolved by objective evaluation of each case. Investigators are encouraged to contact committee members in their field to discuss any issues arising concerning allergen nomenclature.